The US Department of Health and Human Services (HHS) has released final guidance for the second cycle of Medicare drug price negotiations. 3 October 2024
The Russian government has finalized the rules for granting preference to domestic drugs in public procurements, which will come into force in 2025. 1 October 2024
The Danish government is to remove the rules that currently prohibit the purchase of medicines from countries outside the European Union (EU) in a move that has not been welcomed by pharma. 30 September 2024
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR). 30 September 2024
The generics and biosimilars trade group, Medicines for Europe, has put out a strong message amid ongoing discussions on a European Union (EU) Critical Medicines Act. 26 September 2024
US biotech Emergent BioSolutions revealed it has secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox and mpox product portfolio. 26 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
President Biden has said the USA will commit at least $500 million to support African countries in battling the ongoing mpox outbreak in Central and Eastern Africa. 25 September 2024
The Pharmaceutical Research and Manufacturers of America (PhRMA) is continuing its legal challenge against the US government’s drug pricing reforms. 24 September 2024
The Foundation for Economic and Industrial Research and Greek pharma trade group the Hellenic Association of Pharmaceutical Companies have presented two studies reflecting the industry’s importance. 23 September 2024
Basilea Pharmaceutica announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) has awarded Basilea an Other Transaction Agreement (OTA), under OTA number 75A50124C00033. 20 September 2024
Novo Nordisk is under increasing pressure over the cost of its blockbuster drugs in the USA, as chief executive Lars Fruergaard Jørgensen prepares to testify before a powerful Senate committee. 18 September 2024
The research based pharmaceutical industry has welcomed Mario Draghi’s report, published by the European Commission, outlining proposals on how Europe can regain its competitive edge and the critical role of innovative industries in achieving this. 11 September 2024
Even as emerging signs of a thaw in the broader Indian start-up funding landscape were evident, the Competition Commission of India (CCI) has tightened its exemption list under new combination rules. 11 September 2024
The US House of Representatives has passed the BIOSECURE Act, gaining bipartisan support with a vote of 306–81. Nearly all of the votes against the bill came from Democrats. 10 September 2024
The Cell and Gene Therapy Catapult (CGT Catapult) has highlighted what it regards as the UK's potential to lead the global cell and gene therapy sector. 5 September 2024
The budget on October 30 is an opportunity to end short-termism, cut waste, and attract long-term investment to the country’s economy with a sector-targeted R&D tax relief policy, according to the UK BioIndustry Association (BIA). 3 September 2024
The Danish Pharmaceutical Industry Association, Lif, has given its verdict on the government financial bill setting out new priorities in health in 2025. 2 September 2024
Marseille-based ImCheck Therapeutics has received 20.2 million euros ($22.4 million) in non-dilutive funding as part of the i-Démo call for projects under the France 2030 Plan operated by Bpifrance on behalf of the French government. 29 August 2024
In India, 33 drugs supplied to various government hospitals and stores in Arunachal Pradesh were found to be of sub-standard quality during laboratory tests. 30 August 2016
To push India into top five pharmaceutical innovation hubs by 2020 and establish global presence by launching one out of every five-10 drugs discovered in India at a global level, the government is preparing for multi-billion dollar investment with 50% public funding through its public private partnership (PPP) model to enhance innovation capability, a new study reveals. 30 August 2016
The Russian Federal Anti-Monopoly Service (FAS) has started investigations regarding the recent detection of a cartel in the Russian pharmaceutical market, which was created by some leading local drugmakers and global majors operating in the Russian market, according to press-service of the FAS, reports The Pharma Letter’s local correspondent. 26 August 2016
Republican Iowa Senator Chuck Grassley has asked the manufacturer of the EpiPen, used for emergency treatment for life-threatening allergic reactions, to explain a steep price increase in the product in recent years. 24 August 2016
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. 23 August 2016
US trade group PhRMA has said that new government data on the cost of prescription drugs paints a ‘misleading picture’ about the Medicare Part D program because it fails to include discounts and rebates negotiated directly with manufacturers. 19 August 2016
A ‘huge blow to patients’ and the realization of ‘our worst fears' about the re-launched Cancer Drugs Fund (CDF) is how one charity has reacted to the recommended discontinuation of oncology treatments in England. 18 August 2016
Falling stock markets, political uncertainty and continued global economic weakness all contributed to a mixed first half for the pharma and medtech industries, according to a new report. 17 August 2016
A report on why UK cancer patients are missing out on drugs available elsewhere is ‘too simplistic’ in attributing the problem to failed negotiations with pharma companies, according to the Association of the British Pharmaceuticals Industry (ABPI). 15 August 2016
Much like a soccer player having to adapt his game when he goes to play in a different national league, pharma companies need a different approach to gaining regulatory approval and reimbursement in different major markets. 15 August 2016
British businesses and universities will have certainty over future funding and should continue to bid for competitive European Union funds while the UK remains a member of the European Union, ahead of leaving in the so-called ‘Brexit’ move following the referendum vote to leave, according to a government announcement on Saturday. 14 August 2016
The overwhelming majority of US patients’ groups opposing a Medicare Part B proposal to reduce drug expenditures got funding from the pharmaceutical industry, according to a new Public Citizen report. 9 August 2016
In our weekly expert view piece, Victoria Hordern, privacy and cybersecurity lawyer at Hogan Lovells, examines the UK government's proposals on data security and data sharing in the health sector. 9 August 2016
Russian President Vladimir Putin has instructed the national Federal Anti-Monopoly Service (FAS) and the federal government to continue regular monitoring of drug prices in the domestic market, as well as their compliance with the current market realities. 8 August 2016
As the trade ministers of the 16 countries negotiating the Regional Comprehensive Economic Partnership (RCEP) meet in Laos on August 5 to resolve differences that are holding back negotiations, international medical humanitarian organization Médecins Sans Frontières (MSF) is calling for the removal of damaging intellectual property provisions – known as TRIPS-plus provisions – that would lock in high drug prices and endanger the health of millions of people across the globe. 5 August 2016
In our weekly expert view piece, patent attorney and head of life sciences at intellectual property firm Withers & Rogers LLP, Adrian Tombling, examines GSK's decision to invest £275m at three of its UK manufacturing sites. 2 August 2016
The British government has confirmed the post of Life Sciences Minister will now be shared by two politicians working across separate departments. 1 August 2016